U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403812) titled 'Assessing DCog Short for Neurotoxicity in CAR-T' on Feb. 04.
Brief Summary: The aim of this study is to determine the effectiveness of DCog Short, a self-reporting, iPad-based application tool, in assessing neurotoxicity in participants undergoing CAR-T cell therapy.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Neurotoxicity
Neurotoxicity Syndromes
Hematologic Malignancy
Immune Effector Cell Associated Neurotoxicity Syndrome
Intervention:
BEHAVIORAL: DCog Short
An iPad-based cognitive assessment instrument to evaluate neurotoxicity and consisting of a series of tests that measure various aspects of cogni...